Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 24601-74-9
2. L-valine N-carboxyanhydride
3. (4s)-4-propan-2-yl-1,3-oxazolidine-2,5-dione
4. (4s)-4-(propan-2-yl)-1,3-oxazolidine-2,5-dione
5. L-4-isopropyl-2,5-oxazolidinedione
6. Mfcd03411320
7. Dl-valine Nca
8. L-valine Nca
9. N-carboxy-dl-valine Anhydride
10. 2,5-oxazolidinedione, 4-(1-methylethyl)-, (s)-
11. Schembl2071787
12. Dtxsid00432488
13. Amy22687
14. Zaa60174
15. Ac5719
16. Zinc72400702
17. Akos016843858
18. (s)-4-isopropyl-2,5-oxazolidinedione
19. (4s)-4-isopropyloxazolidine-2,5-dione
20. (s)-4-isopropyl-oxazolidine-2,5-dione
21. Cs-16607
22. Cs-0101223
23. 601i749
24. A817388
25. J-015585
26. 2,5-oxazolidinedione, 4-(1-methylethyl)-, (4s)-
| Molecular Weight | 143.14 g/mol |
|---|---|
| Molecular Formula | C6H9NO3 |
| XLogP3 | 0.9 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 3 |
| Rotatable Bond Count | 1 |
| Exact Mass | 143.058243149 g/mol |
| Monoisotopic Mass | 143.058243149 g/mol |
| Topological Polar Surface Area | 55.4 Ų |
| Heavy Atom Count | 10 |
| Formal Charge | 0 |
| Complexity | 176 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 1 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
A L-Val-NCA manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of L-Val-NCA, including repackagers and relabelers. The FDA regulates L-Val-NCA manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. L-Val-NCA API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of L-Val-NCA manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A L-Val-NCA supplier is an individual or a company that provides L-Val-NCA active pharmaceutical ingredient (API) or L-Val-NCA finished formulations upon request. The L-Val-NCA suppliers may include L-Val-NCA API manufacturers, exporters, distributors and traders.
click here to find a list of L-Val-NCA suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
L-Val-NCA Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of L-Val-NCA GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right L-Val-NCA GMP manufacturer or L-Val-NCA GMP API supplier for your needs.
A L-Val-NCA CoA (Certificate of Analysis) is a formal document that attests to L-Val-NCA's compliance with L-Val-NCA specifications and serves as a tool for batch-level quality control.
L-Val-NCA CoA mostly includes findings from lab analyses of a specific batch. For each L-Val-NCA CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
L-Val-NCA may be tested according to a variety of international standards, such as European Pharmacopoeia (L-Val-NCA EP), L-Val-NCA JP (Japanese Pharmacopeia) and the US Pharmacopoeia (L-Val-NCA USP).
LOOKING FOR A SUPPLIER?
